Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G J Veldhuis

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Advances in Experimental Medicine and Biology|January 1, 1988
B cell precursor populations in fetal and neonatal rat liver: frequency, topography and antigenic phenotypeG J Veldhuis, D Opstelten
Skin Research and Technology : Official Journal of International Society for Bioengineering and the Skin (ISBS) [And] International Society for Digital Imaging of Skin (ISDIS) [And] International Society for Skin Imaging (ISSI)|September 14, 2001
Proposal and evaluation of a Monte Carlo model for hair regrowth following pluckingM E Roersma, G J Veldhuis
The Netherlands Journal of Medicine|December 25, 2003
New developments in staging and follow-up of patients with Hodgkin's lymphomaD J van Spronsen, G J Veldhuis
Leukemia & Lymphoma|February 1, 1996
Potential use of recombinant human interleukin-6 in clinical oncologyG J Veldhuis, P H Willemse, N H Mulder, et al.
Annals of Hematology|July 1, 1996
A case of localized Castleman's disease with systemic involvement: treatment and pathogenetic aspectsG J Veldhuis, A H van der Leest, J T de Wolf, et al.
Optics Letters|December 20, 2007
Mechano-optical waveguide on-off intensity modulatorG J Veldhuis, C Gui, T Nauta, et al.
British Journal of Cancer|January 1, 1997
Paclitaxel, ifosfamide and cisplatin with granulocyte colony-stimulating factor or recombinant human interleukin 3 and granulocyte colony-stimulating factor in ovarian cancer: a feasibility studyG J Veldhuis, P H Willemse, J H Beijnen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 1995
Recombinant human interleukin-3 to dose-intensify carboplatin and cyclophosphamide chemotherapy in epithelial ovarian cancer: a phase I trialG J Veldhuis, P H Willemse, M M van Gameren, et al.
International Journal of Pharmaceutics|December 16, 2014
Biocompatibility of poly(D,L-lactic-co-hydroxymethyl glycolic acid) microspheres after subcutaneous and subcapsular renal injectionF Kazazi-Hyseni, J Zandstra, E R Popa, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 1, 1995
Toxicity and efficacy of escalating dosages of recombinant human interleukin-6 after chemotherapy in patients with breast cancer or non-small-cell lung cancerG J Veldhuis, P H Willemse, D T Sleijfer, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Advances in Experimental Medicine and Biology|January 1, 1988
B cell precursor populations in fetal and neonatal rat liver: frequency, topography and antigenic phenotypeG J Veldhuis, D Opstelten
Skin Research and Technology : Official Journal of International Society for Bioengineering and the Skin (ISBS) [And] International Society for Digital Imaging of Skin (ISDIS) [And] International Society for Skin Imaging (ISSI)|September 14, 2001
Proposal and evaluation of a Monte Carlo model for hair regrowth following pluckingM E Roersma, G J Veldhuis
The Netherlands Journal of Medicine|December 25, 2003
New developments in staging and follow-up of patients with Hodgkin's lymphomaD J van Spronsen, G J Veldhuis
Leukemia & Lymphoma|February 1, 1996
Potential use of recombinant human interleukin-6 in clinical oncologyG J Veldhuis, P H Willemse, N H Mulder, et al.
Annals of Hematology|July 1, 1996
A case of localized Castleman's disease with systemic involvement: treatment and pathogenetic aspectsG J Veldhuis, A H van der Leest, J T de Wolf, et al.
Optics Letters|December 20, 2007
Mechano-optical waveguide on-off intensity modulatorG J Veldhuis, C Gui, T Nauta, et al.
British Journal of Cancer|January 1, 1997
Paclitaxel, ifosfamide and cisplatin with granulocyte colony-stimulating factor or recombinant human interleukin 3 and granulocyte colony-stimulating factor in ovarian cancer: a feasibility studyG J Veldhuis, P H Willemse, J H Beijnen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 1995
Recombinant human interleukin-3 to dose-intensify carboplatin and cyclophosphamide chemotherapy in epithelial ovarian cancer: a phase I trialG J Veldhuis, P H Willemse, M M van Gameren, et al.
International Journal of Pharmaceutics|December 16, 2014
Biocompatibility of poly(D,L-lactic-co-hydroxymethyl glycolic acid) microspheres after subcutaneous and subcapsular renal injectionF Kazazi-Hyseni, J Zandstra, E R Popa, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 1, 1995
Toxicity and efficacy of escalating dosages of recombinant human interleukin-6 after chemotherapy in patients with breast cancer or non-small-cell lung cancerG J Veldhuis, P H Willemse, D T Sleijfer, et al.
Pageof 2